Sichenzia Ross Friedman Ference LLP Represents Viatar CTC Solutions Inc. in a $4.2 Million Private Placement
Press Release – New York, NY – March 3, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Viatar CTC Solutions Inc., a medical technology company focused on the treatment of patients with metastatic cancer, in a private placement of $4.2 million of Series B Preferred Stock.
In connection with the offering, the Company sold approximately 1.7 million shares of Series B Preferred Stock for an aggregate purchase price of approximately $4.2 million (including shares of a private company valued at approximately $3.7 million and cash of $500,000). The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and Darrin Ocasio and associate Jeff Cahlon.
- Two Bright Sides of Estate Planning During COVID-19 - July 1, 2020
- Sichenzia Ross Ference LLP Represents Aegis Capital in $5.4 Million Public Offering of Avinger, Inc. Common Stock - June 26, 2020
- Sichenzia Ross Ference LLP Represents Hudson Capital Inc. in $3.7 Million Registered Direct Offering - June 24, 2020